Anbogen Inks Deal With BeiGene For Colorectal Cancer Therapy
27 Sep 2024 //
BIOSPECTRUM ASIA
Anbogen Completes A+ Financing For ABT-301 Phase II Trial
01 Jul 2024 //
PR NEWSWIRE
Anbogen Secures 12.5 Million in Series A Funding
31 Jan 2024 //
PR NEWSWIRE